Epigenetic modulation of BARD1 to enhance anti-VEGF therapy.

Bayraktar E, Rodriguez-Aguayo C, Stur E, Kumar S, Mangala LS, Jennings NB, Bayram NN, Corvigno S, Asare A, Ivan C, Kim MS, Vu TC, Hanjra P, Kim S, Ahumada AL, Wu W, Lee S, Szymanowska A, Oztatlici H, Estecio MR, Lee JS, Jain AK, Sahni N, Hagan JP, Baylin S, Liu J, Lopez-Berestein G, Pradeep S, Sood AK.

Open source

DOI: 10.1016/j.xcrm.2025.102329
Published: 2025-09-03
Container: Cell Rep Med
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2025.102329,
  title = {Epigenetic modulation of BARD1 to enhance anti-VEGF therapy.},
  author = {Bayraktar E and  Rodriguez-Aguayo C and  Stur E and  Kumar S and  Mangala LS and  Jennings NB and  Bayram NN and  Corvigno S and  Asare A and  Ivan C and  Kim MS and  Vu TC and  Hanjra P and  Kim S and  Ahumada AL and  Wu W and  Lee S and  Szymanowska A and  Oztatlici H and  Estecio MR and  Lee JS and  Jain AK and  Sahni N and  Hagan JP and  Baylin S and  Liu J and  Lopez-Berestein G and  Pradeep S and  Sood AK.},
  year = {2025},
  journal = {Cell Rep Med},
  doi = {10.1016/j.xcrm.2025.102329},
  url = {https://doi.org/10.1016/j.xcrm.2025.102329}
}

RIS

TY  - JOUR
TI  - Epigenetic modulation of BARD1 to enhance anti-VEGF therapy.
AU  - Bayraktar E
AU  -  Rodriguez-Aguayo C
AU  -  Stur E
AU  -  Kumar S
AU  -  Mangala LS
AU  -  Jennings NB
AU  -  Bayram NN
AU  -  Corvigno S
AU  -  Asare A
AU  -  Ivan C
AU  -  Kim MS
AU  -  Vu TC
AU  -  Hanjra P
AU  -  Kim S
AU  -  Ahumada AL
AU  -  Wu W
AU  -  Lee S
AU  -  Szymanowska A
AU  -  Oztatlici H
AU  -  Estecio MR
AU  -  Lee JS
AU  -  Jain AK
AU  -  Sahni N
AU  -  Hagan JP
AU  -  Baylin S
AU  -  Liu J
AU  -  Lopez-Berestein G
AU  -  Pradeep S
AU  -  Sood AK.
PY  - 2025
JO  - Cell Rep Med
DO  - 10.1016/j.xcrm.2025.102329
UR  - https://doi.org/10.1016/j.xcrm.2025.102329
ER  -

APA

E, B., C, R., E, S., S, K., LS, M., NB, J., NN, B., S, C., A, A., C, I., MS, K., TC, V., P, H., S, K., AL, A., W, W., S, L., A, S., H, O., MR, E., JS, L., AK, J., N, S., JP, H., S, B., J, L., G, L., S, P., & AK., S. (2025). Epigenetic modulation of BARD1 to enhance anti-VEGF therapy.. Cell Rep Med. https://doi.org/10.1016/j.xcrm.2025.102329

Source records

europe-pmc · retrieved 2026-09-26T02:44:41.474Z
doaj · retrieved 2026-09-26T02:44:41.468Z